By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Anti-angiogenic ophthalmic agents > Brolucizumab ophthalmic
Anti-angiogenic ophthalmic agents

Brolucizumab ophthalmic

https://themeditary.com/drug/brolucizumab-ophthalmic-7271.html
Medically Reviewed by Glamora Samuels, MD TheMediTary.Com | Reviewed: Aug 15, 2023  Additional Content by TheMediTary.Com

Generic name: brolucizumab ophthalmic [ broe-lue-siz-ue-mab ]

Drug class: Anti-angiogenic ophthalmic agents

Dosage form: intravitreal solution (dbll 6 mg/0.05 ml)

Availability: Prescription only

Pregnancy & Lactation: Risk data available

Brand names: Beovu, Brolucizumab (monograph)

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Brolucizumab ophthalmic?

Brolucizumab is made from a human antibody fragment. It works by keeping new blood vessels from forming under the retina (a sensory membrane that lines the inside of the eye). In people with certain types of eye disorders, new blood vessels grow under the retina where they leak blood and fluid.

Brolucizumab ophthalmic (for the eyes) is used to treat the "wet form" of age-related macular degeneration.

Brolucizumab ophthalmic may also be used for purposes not listed in this medication guide.

Warnings

Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.

How should I take Brolucizumab ophthalmic

Brolucizumab is given as an injection into your eye. Your doctor will use a medicine to numb your eye before giving you the injection. You will receive this injection in your doctor's office or other clinic setting.

For a short time after your injection, your eyes will be checked periodically to make sure the injection has not caused any side effects.

Brolucizumab is usually given once per month for 3 months, and then once every 8 to 12 weeks.

Follow your doctor's dosing instructions very carefully. The timing of your monthly injections is very important for this medication to be effective.

Dosing information

Usual Adult Dose for Macular Degeneration:

Initial dose: 6 mg by intravitreal injection once a month for the first 3 doses
Maintenance dose: 6 mg by intravitreal injection once every 8 to 12 weeks

Comments:
-This drug should be administered by a qualified physician.
-Once monthly injections should be administered approximately every 25 to 31 days.
-In clinical trials, the maintenance dosing interval was guided by visual and anatomical measures of disease activity; the utility of these measures has not been established.

Use: For the treatment of neovascular (wet) age-related macular degeneration (AMD).

Detailed Brolucizumab dosage information
Brolucizumab ophthalmic Dosage information (more detail)

Before Taking

You should not use brolucizumab if you are allergic to it, or if you have:

  • inflammation inside your eye; or

  • an infection in or around your eye.

Tell your doctor if you have ever had:

  • glaucoma;

  • cataracts; or

  • a stroke.

Do not use brolucizumab if you are pregnant. It could harm the unborn baby or cause birth defects. Use effective birth control to prevent pregnancy while you are receiving brolucizumab ophthalmic and for at least 1 month after your last dose.

Do not breastfeed while receiving this medicine, and for at least 1 month after your last dose.

What happens if I miss a dose?

Call your doctor for instructions if you miss an appointment for your brolucizumab injection.

What happens if I overdose?

Since brolucizumab ophthalmic is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.

What should I avoid while using Brolucizumab ophthalmic?

This medicine may cause blurred vision and may impair your reactions. Avoid driving or hazardous activity until you know how this medicine will affect you.

Brolucizumab ophthalmic side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Brolucizumab ophthalmic may cause serious side effects. Call your doctor at once if you have:

  • eye pain or redness, swelling around your eyes;

  • discharge or bleeding from the eye;

  • seeing "floaters" in your vision;

  • increased sensitivity to light;

  • decreased vision, tunnel vision, or seeing halos around lights; or

  • sudden numbness or weakness, problems with speech or balance.

Common side effects of brolucizumab ophthalmic may include:

  • blurred vision, hazy vision;

  • increased sensitivity to light;

  • eye pain; or

  • seeing floaters.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

See more: Brolucizumab ophthalmic Side Effects

More about Brolucizumab ophthalmic (Brolucizumab ophthalmic [ broe-lue-siz-ue-mab ])

Dosage information
Brolucizumab ophthalmic Side Effects
During pregnancy
Drug images
Side effects
Breastfeeding Warnings
Drug class: Anti-angiogenic ophthalmic agents

Patient resources

Brolucizumab

Related treatment guides

Diabetic Macular Edema
Macular Degeneration
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by